UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 2, 2012 (March 2, 2012)
Union Pacific Corporation
(Exact name of registrant as specified in its charter)
Utah | 1-6075 | 13-2626465 | ||
(State or other jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
1400 Douglas Street, Omaha, Nebraska | 68179 | |||
(Address of principal executive offices) | (Zip Code) |
(Registrants telephone number, including area code): (402) 544-5000
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 | Departure of Directors; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On March 2, 2012, Union Pacific Corporation issued a press release announcing that James R. Young, President, Chairman and CEO, will take a medical leave of absence effective immediately. John J. Koraleski, Executive Vice President Marketing and Sales of Union Pacific Railroad Company, has been elected to serve as acting President and CEO. Mr. Young will continue to serve as Chairman. A copy of the press release is attached to this Current Report as Exhibit 99.1.
Item 9.01 | Financial Statements and Exhibits. |
(d) | Exhibits. |
99.1 | Press Release of Union Pacific Corporation, dated March 2, 2012. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: March 2, 2012
UNION PACIFIC CORPORATION | ||
By: | /s/ J. Michael Hemmer | |
J. Michael Hemmer | ||
Senior Vice President Law and General Counsel |
Exhibit Index
99.1 | Press Release of Union Pacific Corporation, dated March 2, 2012 |
Exhibit 99.1
UNION PACIFIC CEO TO TAKE MEDICAL LEAVE OF ABSENCE
Omaha, Neb., March 2, 2012 Union Pacific Corporation announced today that its chairman, president and chief executive officer James R. Young will take a medical leave of absence from his responsibilities as president and chief executive officer while he is being treated for recently diagnosed pancreatic cancer. He will remain chairman of the board during his treatment. Pursuant to a long-established plan for such situations, John J. Koraleski, executive vice president-marketing and sales, will serve as acting president and CEO during Mr. Youngs absence.
Steven Rogel, Union Pacifics lead independent director, said: The board has a great deal of confidence in Jack, Rob Knight our CFO, Lance Fritz our head of operations, and the entire management team. We are confident that our company will continue to provide great service to our customers while meeting the financial and safety objectives we have set for ourselves and our shareholders expect.
Since joining the railroad in 1972, Koraleski has held a number of executive positions including controller of Union Pacific Corporation and executive vice president-finance and chief financial officer of Union Pacific Railroad. He also has held positions in the railroads information technologies, real-estate, and administrative departments. He earned both a bachelors and masters degree in business administration from the University of Nebraska at Omaha.
As Jim undergoes his treatment, he has the prayers and support of all 45,000 employees of the UP Team. Our commitment to him, our customers, and our shareholders is continued strong performance of our Company and another record-setting year for Union Pacific, Koraleski said.
The use of a medical leave of absence by the chief executive officer is consistent with company policy established several years ago by the board of directors to ensure management continuity in the case of a change in the status of the CEO. The policy and the assignment of an acting CEO are reviewed regularly by the boards corporate governance and nominating committee.
About Union Pacific
It was 150 years ago that Abraham Lincoln signed the Pacific Railway Act of July 1, 1862, creating the original Union Pacific. One of Americas iconic companies, today Union Pacific Railroad is the principal operating company of Union Pacific Corporation (NYSE: UNP), linking 23 states in the western two-thirds of the country by rail and providing freight solutions and logistics expertise to the global supply chain. From 2000 through 2011, Union Pacific spent more than $31 billion on its network and operations, making needed investments in Americas infrastructure and enhancing its ability to provide safe, reliable, fuel-efficient and environmentally responsible freight transportation. Union Pacifics diversified business mix includes Agricultural Products, Automotive, Chemicals, Energy, Industrial Products and Intermodal. The railroad serves many of the fastest-growing U.S. population centers and emphasizes excellent customer service. Union Pacific operates competitive routes from all major West Coast and Gulf Coast ports to eastern gateways, connects with Canadas rail systems and is the only railroad serving all six major Mexico gateways.
# # #
Media contact: Bob Turner at 402-544-5255 or rwturner@up.com
Investor contact: Michelle Gerhardt at 402-544-4227 or mriesenb@up.com
www.up.com
www.up150.com
www.facebook.com/unionpacific
www.twitter.com/unionpacific